HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology229 papers

Mitral restenosis

Last edited: 4/15/2026

Overview

Mitral restenosis refers to the re-narrowing of the mitral valve after interventions such as surgery, balloon valvuloplasty, or stent implantation, leading to recurrent valvular dysfunction and hemodynamic compromise 1. Despite extensive research and numerous clinical trials, effective prevention and treatment strategies remain limited 1.

Diagnosis

  • Echocardiography (transthoracic or transesophageal) for assessing valve morphology and function 1.
  • Cardiac catheterization to measure pressure gradients and quantify severity 1.
  • Clinical symptoms including dyspnea, fatigue, and signs of heart failure may guide diagnostic evaluation 1.

    • Management

  • First-line treatments:
    • - Repeat surgical intervention (re-repair or replacement) for severe cases 1. - Percutaneous interventions such as transcatheter valve-in-valve procedures for eligible patients 1.
  • Adjunctive treatments:
    • - Antithrombotic therapy to prevent thromboembolic complications (specific drug classes and doses not detailed in current abstracts) 1. - Medical management focusing on heart failure symptoms and risk factor modification 1.

    Special Populations

  • Pregnancy: Specific management strategies for mitral restenosis during pregnancy are not addressed in the provided abstracts 1.
  • Pediatrics: No specific guidelines or studies addressing pediatric mitral restenosis are mentioned 1.
  • Elderly: Considerations for surgical versus percutaneous interventions in elderly patients are not detailed 1.
  • Comorbidities: Management complexities in patients with comorbidities like renal failure or advanced heart disease are not explicitly covered 1.

    • Key Recommendations

  • Consider repeat surgical intervention or transcatheter valve-in-valve procedures for symptomatic mitral restenosis 1 (Evidence: Moderate).
  • Implement antithrombotic prophylaxis to mitigate thromboembolic risks post-intervention 1 (Evidence: Expert opinion).
  • Tailor management strategies based on patient-specific factors including age and comorbidities, though specific guidelines are lacking 1 (Evidence: Weak).

    • References

    1 Chan P. Developments in restenosis. Journal of the renin-angiotensin-aldosterone system : JRAAS 2002. link

    Original source

    1. [1]
      Developments in restenosis. — Chan P Journal of the renin-angiotensin-aldosterone system : JRAAS (2002)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG